✦ LIBER ✦

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

✍ Scribed by Pablo Aschner; Juliana Chan; David R Owens; Sylvie Picard; Edward Wang; Marie-Paule Dain; Valérie Pilorget; Akram Echtay; Vivian Fonseca

Book ID: 117310068
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 277 KB
Volume: 379
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(12)60439-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adding metformin versus insulin dose inc

Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial

✍ Relimpio, F.; Pumar, A.; Losada, F.; Mangas, M.A.; Acosta, D.; Astorga, R. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

To compare the effect of adding metformin to insulin therapy with a moderate increase in insulin dose alone in insulin-treated, poorly controlled Type 2 diabetic patients, 47 consecutive such patients (baseline daily dose Ͼ0.5 IU kg ؊1 and HbA 1c Ͼ8 %) were openly randomized either to a combination

Once weekly exenatide compared with insu

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

✍ Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 496 KB

Comparison of insulin lispro protamine s

Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial

✍ V. Koivisto; S. Cleall; A. E. Pontiroli; D. Giugliano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Combined therapy with insulin lispro mix

Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

✍ James K. Malone; Lisa F. Kerr; Barbara N. Campaigne; Richard A. Sachson; John H. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Insulin degludec, an ultra-long-acting b

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

✍ Bernard Zinman; Greg Fulcher; Paturi V Rao; Nihal Thomas; Lars A Endahl; Thue Jo 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 203 KB

Similar progression of diabetic retinopa

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J.-P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 218 KB